BeiGene Ltd ADR buy Guggenheim
Start price
27.02.24
/
50%
€166.00
Target price
27.02.25
€317.85
Performance (%)
-9.04%
Price
02.05.24
€151.00
Summary
This prediction is currently active. With a performance of -9.04%, the BUY prediction for BeiGene Ltd ADR by Guggenheim is down slightly. This prediction currently runs until 27.02.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BeiGene Ltd ADR | 16.154% | 16.154% |
iShares Core DAX® | 0.000% | -2.064% |
iShares Nasdaq 100 | 0.626% | -2.884% |
iShares Nikkei 225® | 1.568% | -5.892% |
iShares S&P 500 | 0.334% | -2.281% |
Comments by Guggenheim for this prediction
In the thread BeiGene Ltd ADR diskutieren
BeiGene, Ltd. (NASDAQ: BGNE) had its price target lowered by analysts at Guggenheim from $350.00 to $345.00. They now have a "buy" rating on the stock.
Ratings data for BGNE provided by MarketBeat
Stopped prediction by Guggenheim for BeiGene Ltd ADR
BeiGene Ltd ADR
Start price
Target price
Perf. (%)
€214.00
28.02.23
28.02.23
€329.84
28.02.24
28.02.24
-26.17%
29.02.24
29.02.24